top of page
Starting August 1, 2024, Quickarrays Inc. will be taking over Pantomics Inc. to
provide all products and services. Please visit Quickarrays Inc. for more information.
SERVICES
CUSTOM TMA
ROUTINE PATHOLOGY
IHC / IMMUNOFLUORESCENCE
ISH / FISH
CONTRACTED SERVICES
PRIMARY IHC ANTIBODIES
PATHOLOGY FIELD
DETECTION SYSTEMS
ANCILLARIES
CONTROL TMA
Hermatopathology
THC961
Thyroid cancer tissue array, set 1, non-overlapping with THC962, 96 cores, 48 cases from normal, premalignant and cancer tissues with progressive grades and TNM stages in duplicates.
Specification
Data Sheet
TNM Grading
Downloads
Price
Size
Availability
$289
1 slide
In-Stock
A | |
B | |
C | |
D | |
E | |
F | |
G | |
H | |
TNM Classification : Thyroid carcinoma
T- Primary tumor
TX - Primary tumor cannot be assessed
TO - No evidence of primary tumor
T1 - Tumor 1 cm or less in greatest dimension, limited to the thyroid
T2 - Tumor more than 1 cm but not more than 4 cm in greatest dimension, limited to the thyroid
T3 - Tumor more than 4 cm in greatest dimension, limited to the thyroid
T4 - Tumor of any size extending beyond the thyroid capsule
N - Regional lymph nodes
NX - Regional lymph nodes cannot be assessed
NO - No regional lymph node metastasis
N1 - Regional lymph node metastasis
N1a - Metastasis in ipsilateral cervical lymph nodes
N1b - Metastasis in bilateral, midline, or contralateral cervical or mediastinal lymph nodes
M - Distant metastasis
MX - Distant metastasis cannot be assessed
MO - No distant metastasis
M1 - Distant metastasis
Histopathologic Types
- Papillary carcinoma
- Follicular carcinoma
- Medullary carcinoma
- Undifferentiated (anaplastic) carcinoma
Human
48
96
1.5mm
4um
8
12
Paraffin
Notes:
All tissues were fixed in 10% neutral buffered formalin for 24 hours and processed using identical SOPs. Sections were picked onto Superfrost Plus or Startfrost Adhesive slides. They all have a guaranteed six month shelf-life at 4C from the date of shipment. Additional cores not listed are orientation markers and have no data. There maybe <5% core loss per slide but the core retention rate should be >90%.
Bake at 60C for 30 minutes before use. If antigen retrieving is needed, it is always a good idea to start with a protocol with weak to mild strength. Please check our TNM guide as a reference. For IHC related information on products that provide them, please contact us at info@pantomics.com for the most up-to-date information.
For research use only. Designed for IHC or ISH based protein or RNA tissue profiling in evolution and progression of thyroid cancers.
ARRAY POSITION | IMAGE | SEX | AGE | ANATOMIC SITE | PATHOLOGY | GRADE | STAGE (TNM) |
|---|---|---|---|---|---|---|---|
A01 | F | 48 | Thyroid | Normal | |||
A02 | F | 43 | Thyroid | Normal | |||
A03 | F | 43 | Thyroid | Normal | |||
A04 | F | 51 | Thyroid | Subacute thyroiditis | |||
A05 | F | 57 | Thyroid | Adenoma, fetal type | |||
A06 | F | 50 | Thyroid | Hashimoto's thyroiditis | |||
A07 | F | 50 | Thyroid | Multi-nodular goiter | |||
A08 | F | 53 | Thyroid | Multi-nodular goiter | |||
A09 | M | 63 | Thyroid | Multi-nodular goiter | |||
A10 | F | 41 | Thyroid | Multi-nodular goiter | |||
A11 | F | 40 | Thyroid | Adenoma | |||
A12 | M | 28 | Thyroid | Follicular adenoma | |||
B01 | F | 48 | Thyroid | Normal | |||
B02 | F | 43 | Thyroid | Normal | |||
B03 | F | 43 | Thyroid | Normal | |||
B04 | F | 51 | Thyroid | Subacute thyroiditis | |||
B05 | F | 57 | Thyroid | Adenoma, fetal type | |||
B06 | F | 50 | Thyroid | Hashimoto's thyroiditis | |||
B07 | F | 50 | Thyroid | Multi-nodular goiter | |||
B08 | F | 53 | Thyroid | Multi-nodular goiter | |||
B09 | M | 63 | Thyroid | Multi-nodular goiter | |||
B10 | F | 41 | Thyroid | Multi-nodular goiter | |||
B11 | F | 40 | Thyroid | Adenoma | |||
B12 | M | 28 | Thyroid | Follicular adenoma | |||
C01 | F | 33 | Thyroid | Adenoma, fetal type | |||
C02 | M | 44 | Thyroid | Simple colloid adenoma | |||
C03 | F | 56 | Thyroid | Graves' disease | |||
C04 | F | 27 | Thyroid | Hashimoto's thyroiditis | |||
C05 | F | 18 | Thyroid | Graves' disease | |||
C06 | F | 53 | Thyroid | Hashimoto's thyroiditis | |||
C07 | F | 24 | Thyroid | Papillary adenocarcinoma | II~III | T2N1M0 | |
C08 | M | 50 | Thyroid | Papillary adenocarcinoma | I~II | T2N0M0 | |
C09 | M | 57 | Thyroid | Papillary adenocarcinoma | T4N1M0 | ||
C10 | F | 27 | Thyroid | Papillary adenocarcinoma | T2N0M0 | ||
C11 | M | 52 | Thyroid | Papillary adenocarcinoma | T2N1M0 | ||
C12 | F | 19 | Thyroid | Follicular papillary adenocarcinoma | T2N1M0 | ||
D01 | F | 33 | Thyroid | Adenoma, fetal type | |||
D02 | M | 44 | Thyroid | Simple colloid adenoma | |||
D03 | F | 56 | Thyroid | Graves' disease | |||
D04 | F | 27 | Thyroid | Hashimoto's thyroiditis | |||
D05 | F | 18 | Thyroid | Graves' disease | |||
D06 | F | 53 | Thyroid | Hashimoto's thyroiditis | |||
D07 | F | 24 | Thyroid | Papillary adenocarcinoma | II~III | T2N1M0 | |
D08 | M | 50 | Thyroid | Papillary adenocarcinoma | I~II | T2N0M0 | |
D09 | M | 57 | Thyroid | Papillary adenocarcinoma | T4N1M0 | ||
D10 | F | 27 | Thyroid | Papillary adenocarcinoma | T2N0M0 | ||
D11 | M | 52 | Thyroid | Papillary adenocarcinoma | T2N1M0 | ||
D12 | F | 19 | Thyroid | Follicular papillary adenocarcinoma | T2N1M0 | ||
E01 | F | 31 | Thyroid | Papillary adenocarcinoma | III | T3N0M0 | |
E02 | M | 16 | Thyroid | Follicular carcinoma | T3N1M0 | ||
E03 | F | 33 | Thyroid | Papillary adenocarcinoma | T2N0M0 | ||
E04 | M | 34 | Thyroid | Follicular papillary adenocarcinoma | T2N1M0 | ||
E05 | F | 44 | Thyroid | Papillary adenocarcinoma | T2N0M0 | ||
E06 | F | 42 | Thyroid | Papillary adenocarcinoma | T2N0M0 | ||
E07 | F | 64 | Thyroid | Papillary adenocarcinoma | T2N1M0 | ||
E08 | M | 51 | Thyroid | Papillary adenocarcinoma | T1N0M0 | ||
E09 | F | 22 | Thyroid | Papillary adenocarcinoma | T2N0M0 | ||
E10 | F | 30 | Thyroid | Papillary adenocarcinoma | T2N0M0 | ||
E11 | F | 38 | Thyroid | Papillary adenocarcinoma | T3N0M0 | ||
E12 | F | 11 | Thyroid | Papillary adenocarcinoma | T3N1M0 | ||
F01 | F | 31 | Thyroid | Papillary adenocarcinoma | III | T3N0M0 | |
F02 | M | 16 | Thyroid | Follicular carcinoma | T3N1M0 | ||
F03 | F | 33 | Thyroid | Papillary adenocarcinoma | T2N0M0 | ||
F04 | M | 34 | Thyroid | Follicular papillary adenocarcinoma | T2N1M0 | ||
F05 | F | 44 | Thyroid | Papillary adenocarcinoma | T2N0M0 | ||
F06 | F | 42 | Thyroid | Papillary adenocarcinoma | T2N0M0 | ||
F07 | F | 64 | Thyroid | Papillary adenocarcinoma | T2N1M0 | ||
F08 | M | 51 | Thyroid | Papillary adenocarcinoma | T1N0M0 | ||
F09 | F | 22 | Thyroid | Papillary adenocarcinoma | T2N0M0 | ||
F10 | F | 30 | Thyroid | Papillary adenocarcinoma | T2N0M0 | ||
F11 | F | 38 | Thyroid | Papillary adenocarcinoma | T3N0M0 | ||
F12 | F | 11 | Thyroid | Papillary adenocarcinoma | T3N1M0 | ||
G01 | M | 58 | Thyroid | Papillary adenocarcinoma | T3N0M1 | ||
G02 | M | 19 | Thyroid | Papillary adenocarcinoma | T2N0M0 | ||
G03 | M | 58 | Thyroid | Papillary adenocarcinoma | T1N0M0 | ||
G04 | F | 41 | Thyroid | Papillary adenocarcinoma | T2N0M0 | ||
G05 | M | 26 | Thyroid | Follicular carcinoma | T2N1M0 | ||
G06 | F | 44 | Thyroid | Follicular carcinoma | T2N0M0 | ||
G07 | F | 54 | Thyroid | Papillary adenocarcinoma | T2N0M0 | ||
G08 | M | 65 | Thyroid | Undifferentiated carcinoma | T3N0M0 | ||
G09 | F | 79 | Thyroid | Undifferentiated carcinoma | T3N1M0 | ||
G10 | M | 63 | Thyroid | Medullary carcinoma | T2N1M0 | ||
G11 | F | 25 | Thyroid | Lymphoma, diffuse large B cell lymphoma | |||
G12 | F | 77 | Thyroid | Lymphoma, MALT-B cell lymphoma, high grade | |||
H01 | M | 58 | Thyroid | Papillary adenocarcinoma | T3N0M1 | ||
H02 | M | 19 | Thyroid | Papillary adenocarcinoma | T2N0M0 | ||
H03 | M | 58 | Thyroid | Papillary adenocarcinoma | T1N0M0 | ||
H04 | F | 41 | Thyroid | Papillary adenocarcinoma | T2N0M0 | ||
H05 | M | 26 | Thyroid | Follicular carcinoma | T2N1M0 | ||
H06 | F | 44 | Thyroid | Follicular carcinoma | T2N0M0 | ||
H07 | F | 54 | Thyroid | Papillary adenocarcinoma | T2N0M0 | ||
H08 | M | 65 | Thyroid | Undifferentiated carcinoma | T3N0M0 | ||
H09 | F | 79 | Thyroid | Undifferentiated carcinoma | T3N1M0 | ||
H10 | M | 63 | Thyroid | Medullary carcinoma | T2N1M0 | ||
H11 | F | 25 | Thyroid | Lymphoma, diffuse large B cell lymphoma | |||
H12 | F | 77 | Thyroid | Lymphoma, MALT-B cell lymphoma, high grade | |||
null |
bottom of page